Presentation TCT 2025 TCT 62: Long-Term Outcomes of Patients at Both High Ischemic and Bleeding Risk (Bi-Risk) on Clopidogrel-Based Dual Antiplatelet Therapy, Insights from the UF-GENOTYPE Registry. Presenter: Claudio Laudani October 28, 2025
Presentation TCT 2025 TCT 1013: Incidence of in-stent thrombotic events in patients undergoing percutaneous coronary intervention (PCI) with stent placement started on dual antiplatelet therapy (DAPT) Presenter: Sulayma Naser Agha October 28, 2025
Presentation TCT 2025 TCT 1006: Dual Antiplatelet Therapy Duration and Risk of Stent Thrombosis in Complex Percutaneous Coronary Intervention: a Meta-Analysis Presenter: Fiorenzo Simonetti October 27, 2025
Presentation TCT 2025 TCT 1007: Short Vs. Long Dual Antiplatelet Therapy for Chronic Total Occlusions Coronary Interventions: A systematic Review and Bayesian Meta-Analysis Presenter: Ricardo Fonseca Oliveira Suruagy-Motta October 27, 2025
Presentation TCT 2025 TCT 995: Less Is More? P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy following PCI In Acute Coronary Syndrome: A Meta-Analysis of Reconstructed Time-to-Event Data Presenter: Paulo Roberto Tartuce Filho October 27, 2025
Presentation TCT 2025 TCT 998: Dual Antiplatelet Therapy (DAT) versus Triple Therapy (TAT) post Percutaneous Coronary Intervention (PCI) in patients requiring Chronic Anticoagulation: Meta-analysis. Presenter: Kanishk Aggarwal October 27, 2025
Presentation TCT 2025 TCT 1823: Drug-Coated Balloon Treatment Despite an Angiographic Dissection to Avoid Dual Antiplatelet Therapy in a Patient Needing Vascular Surgery in Short Time Presenter: Marco Luciano Rossi October 26, 2025
Presentation TCT 2025 TCT 922: Duration-Dependent Outcomes of Dual Antiplatelet Therapy Following Peripheral Endovascular Revascularization: A Systematic Review and Meta-Analysis of Target Vessel Patency, Limb Salvage, and Safety Events Presenter: Zeyad Kholeif October 26, 2025
Presentation TCT 2025 Short-Term Anticoagulation Versus Dual Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure Presenter: Josep Rodés-Cabau October 26, 2025
Presentation TCT 2025 TCT 753: Comparative Analysis of Single Versus Dual Antiplatelet Therapy Following Transcatheter Mitral Valve Repair: One-Year Stroke and Bleeding Outcomes Presenter: Rakendu Jayasree Rajendran October 25, 2025
Presentation TCT 2024 3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial Presenter: Hongbo Yang October 30, 2024
Presentation TCT 2024 TCT 289: Different Efficacy of 12-Month Dual Antiplatelet Therapy Following Off-Pump Versus On-Pump Coronary Artery Bypass Grafting Presenter: Woo Jin Jang October 27, 2024
Presentation TCT 2024 TCT 401: Impact of >12-Month Versus =12-Month Dual Antiplatelet Therapy on Long-Term Outcomes After Chronic Total Occlusion Percutaneous Coronary Intervention Presenter: Yao Jiang October 27, 2024
Presentation TCT 2024 TCT 286: Impact of Dual Antiplatelet Therapy on Secondary Revascularization due to Native Vessel Disease Progression v/s Graft Failure After Coronary Artery Bypass Graft Presenter: IFTIKHAR CH October 27, 2024
Presentation TCT 2023 TCT 781: Clinical outcomes of patients treated using 1-month dual antiplatelet therapy after biodegradable-polymer DES implantation Presenter: Masaru Ishida October 26, 2023
Presentation TCT 2023 TCT 706: 3-6 Month vs 12 Month Dual Antiplatelet Therapy After Drug Eluting Stent Placement: An Updated Meta-Analysis Presenter: Aakash Garg October 25, 2023
Presentation TCT 2023 TCT 354: The clinical impact of Dual Antiplatelet Therapy score combined with P2Y12 reactivity unit on East Asian patients who received drug eluting stent implantation; PTRG-DES Consortium Presenter: Seong Huan Choi October 25, 2023
Presentation TCT 2023 TCT 603: Single versus Dual Antiplatelet Therapy for Conservatively Managed Spontaneous Coronary Artery Dissection (SCAD) Patients Presenter: Sophie Offen October 25, 2023
Presentation TCT 2023 TCT 37: The association of CHADS-P2A2RC risk score with clinical outcomes in patients taking P2Y12 inhibitor monotherapy after 3 months of dual antiplatelet therapy following percutaneous coronary intervention Presenter: Ji-Yeon Kim October 25, 2023
Presentation TCT 2023 TCT 30: Predicting Individual Treatment Effects to Determine Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation Presenter: Byeong-Keuk Kim October 25, 2023